TY - JOUR
T1 - Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality
T2 - Observations From the Framingham Study Over 35 Years
AU - Duncan, Meredith S.
AU - Vasan, Ramachandran S.
AU - Xanthakis, Vanessa
N1 - Publisher Copyright:
© 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2019/6/4
Y1 - 2019/6/4
N2 - Background: Elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides, and non-high-density lipoprotein cholesterol (non-HDL-C) and low high-density lipoprotein cholesterol (HDL-C) concentrations correlate with atherosclerotic cardiovascular disease (ASCVD) and mortality. Therefore, understanding how lipid trajectories throughout adulthood impact ASCVD and mortality risk is essential. Methods and Results: We investigated 3875 Framingham Offspring participants (54% women, mean age 48 years) attending ≥1 examination between 1979 and 2014. We evaluated longitudinal correlates of each lipid subtype using mixed-effects models. Next, we clustered individuals into trajectories through group-based modeling. Thereafter, we assessed the prospective association of lipid trajectories with ASCVD and mortality. Male sex, greater body mass index, and smoking correlated with higher TC, LDL-C, triglycerides, non-HDL-C, and lower HDL-C concentrations. We identified 5 TC, HDL-C, and LDL-C trajectories, and 4 triglycerides and non-HDL-C trajectories. Upon follow-up (median 8.2 years; 199 ASCVD events; 256 deaths), elevated TC (>240 mg/dL), LDL-C (>155 mg/dL), or non-HDL-C (>180 mg/dL) concentrations conferred >2.25-fold ASCVD and mortality risk compared with concentrations <165 mg/dL, <90 mg/dL, and <115 mg/dL, respectively ([TC hazard ratio (HR)ASCVD=4.17, 95% CI 1.94–8.99; TC HRdeath=2.47, 95% CI 1.28–4.76] [LDL-C HRASCVD=5.09, 95% CI 1.54–16.85; LDL-C HRdeath=4.04, 95% CI 1.84–8.89] [non-HDL-C HRASCVD=4.60, 95% CI 1.98–10.70; LDL-C HRdeath=3.74, 95% CI 2.03–6.88]). Consistent HDL-C concentrations <40 mg/dL were associated with greater ASCVD and mortality risk than concentrations >70 mg/dL (HRASCVD=3.81, 95% CI 2.04–7.15; HRdeath=2.88, 95% CI 1.70–4.89). Triglycerides trajectories were unassociated with outcomes. Conclusions: Using a longitudinal modeling technique, we demonstrated that unfavorable lipid trajectories over 35 years confer higher ASCVD and mortality risk later in life.
AB - Background: Elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides, and non-high-density lipoprotein cholesterol (non-HDL-C) and low high-density lipoprotein cholesterol (HDL-C) concentrations correlate with atherosclerotic cardiovascular disease (ASCVD) and mortality. Therefore, understanding how lipid trajectories throughout adulthood impact ASCVD and mortality risk is essential. Methods and Results: We investigated 3875 Framingham Offspring participants (54% women, mean age 48 years) attending ≥1 examination between 1979 and 2014. We evaluated longitudinal correlates of each lipid subtype using mixed-effects models. Next, we clustered individuals into trajectories through group-based modeling. Thereafter, we assessed the prospective association of lipid trajectories with ASCVD and mortality. Male sex, greater body mass index, and smoking correlated with higher TC, LDL-C, triglycerides, non-HDL-C, and lower HDL-C concentrations. We identified 5 TC, HDL-C, and LDL-C trajectories, and 4 triglycerides and non-HDL-C trajectories. Upon follow-up (median 8.2 years; 199 ASCVD events; 256 deaths), elevated TC (>240 mg/dL), LDL-C (>155 mg/dL), or non-HDL-C (>180 mg/dL) concentrations conferred >2.25-fold ASCVD and mortality risk compared with concentrations <165 mg/dL, <90 mg/dL, and <115 mg/dL, respectively ([TC hazard ratio (HR)ASCVD=4.17, 95% CI 1.94–8.99; TC HRdeath=2.47, 95% CI 1.28–4.76] [LDL-C HRASCVD=5.09, 95% CI 1.54–16.85; LDL-C HRdeath=4.04, 95% CI 1.84–8.89] [non-HDL-C HRASCVD=4.60, 95% CI 1.98–10.70; LDL-C HRdeath=3.74, 95% CI 2.03–6.88]). Consistent HDL-C concentrations <40 mg/dL were associated with greater ASCVD and mortality risk than concentrations >70 mg/dL (HRASCVD=3.81, 95% CI 2.04–7.15; HRdeath=2.88, 95% CI 1.70–4.89). Triglycerides trajectories were unassociated with outcomes. Conclusions: Using a longitudinal modeling technique, we demonstrated that unfavorable lipid trajectories over 35 years confer higher ASCVD and mortality risk later in life.
KW - cardiovascular disease
KW - life-course
KW - lipids
KW - longitudinal
KW - trajectories
UR - http://www.scopus.com/inward/record.url?scp=85067284499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067284499&partnerID=8YFLogxK
U2 - 10.1161/JAHA.118.011433
DO - 10.1161/JAHA.118.011433
M3 - Article
C2 - 31137992
AN - SCOPUS:85067284499
SN - 2047-9980
VL - 8
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 11
M1 - e011433
ER -